Vitrolife: Steen Solution in lung transplants used in four more patients

By E. Janene Geiss

Philadelphia, Sept. 12 - Vitrolife said Tuesday that four additional lung transplants now have been carried out over a short period of time using Steen Solution, a solution for functional testing of lungs outside the body before transplantation.

A total of six people have received new lungs with the aid of this method, the Kungsbacka, Sweden, biotechnology company said in a news release.

"This is a clinical breakthrough that makes it possible for more organs to be available for patients waiting for transplantation," Magnus Nilsson, Vitrolife's chief executive officer, said in the release.

Testing the lungs for functionality outside of the body increases the number of organs that may be eligible for transplants. The product was approved in January for sales in Europe.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.